Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Scailyte

Explore full profile

Developing artificial intelligence technology for the discovery of complex disease patterns from single-cell data

Basel, SwitzerlandFounded 2017Biotech & Life Sciences
Valuation $25–50M Last recorded · 2023
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Scailyte and the history behind them.

About Scailyte

Scailyte specializes in developing advanced analytical pipelines that convert single cell data into precise clinical applications. The company operates in the healthcare and biotechnology sectors, focusing on the integration of artificial intelligence to unlock the clinical potential of single cell data. Scailyte serves clients in the medical and research fields, providing solutions that aid in complex diagnoses, such as skin T cell lymphoma. The business model revolves around leveraging its multidisciplinary expertise in technology, science, and business to create value through innovative data analysis workflows. Revenue is generated through partnerships, collaborations, and the commercialization of its analytical solutions. The company recently secured pre-series A financing, indicating investor confidence in its growth potential. Scailyte's mission is to save lives by simplifying difficult diagnoses and advancing next-generation clinical applications. Keywords: single cell data, clinical applications, artificial intelligence, healthcare, biotechnology, diagnostics, data analysis, precision medicine, financing, multidisciplinary.

Source: Dealroom company data

At a glance

Founded
2017
Headquarters
Basel, Switzerland
Sector
Biotech & Life Sciences

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

  • ZKB - Zürcher Kantonalbank
  • Swisscom Ventures
  • Hemex
  • Verve Ventures
  • 4FOX Ventures

Series A1 investor entered at this stage

  • Mirabaud & Cie SA
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇨🇭 Switzerland50%
🇩🇪 Germany18.8%
🇧🇬 Bulgaria12.5%
🇺🇸 United States12.5%
🇫🇷 France6.3%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Scailyte on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Scailyte on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.